Reading Time: 4 minutesWith the huge advances in biology, it can seem that areas such as brain scanning are relatively stagnant, but we are starting to see a
Author: Dr Brian Dickie
Reading Time: 4 minutesOn Thursday morning, Profs Paul Cox and Walter Bradley chaired a session titled ‘Beyond Guam: New Aspects of the BMAA Hypothesis’. This was the latest
Reading Time: 2 minutesThe Opening Session theme on how the disease progresses within the Central Nervous System (CNS) continued with the presentation by Prof Stan Appel from Baylor
Reading Time: 9 minutesI’m sure many of you who follow our blog have also been following the discussion on our forum about the Neuraltus trial for a drug called NP001.
Reading Time: < 1 minuteBack in March I mentioned that the Association’s peer review practices were being audited by the Association of Medical Research Charities. I’m pleased to say
Reading Time: 2 minutesForm filling is tedious. For those of us of a certain age (I’m not saying any more!) online form filling is even more stressful. So recently,
Reading Time: < 1 minuteBack in spring 2009 I took part in an awareness raising event organised by the drug company GlaxoSmithKline (GSK). The company was starting to make
Reading Time: 2 minutesIt was then back to the science. Prof Frank Soldner (Massachusetts Institute of Technology) provided an overview of a new and exciting way in which
Reading Time: 2 minutesThe room was crowded at 8am for the first presentation of day two, from Dr Doug Sipp (RIKEN Institute, Japan) on ‘Unregulated ALS/MND treatments and public education’. Dr
Reading Time: 2 minutesOne human neural stem cell line that has cleared the US Government’s regulatory hurdles is that developed by the biotechnology company Neuralstem. To date, nine